Research programme: trifunctional antibodies - TRION Pharma
Alternative Names: EktomunLatest Information Update: 16 Jul 2016
At a glance
- Originator TRION Pharma
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malignant melanoma; Small cell lung cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malignant-melanoma in European Union (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Small-cell-lung-cancer in European Union (Parenteral)
- 05 Jul 2011 Preclinical trials in Small cell lung cancer in European Union (Parenteral)